{"database": "lobbying", "table": "lobbying_activities", "rows": [[2298867, "6598a85d-e699-466a-ab45-b581f92e0cf4", "Q2", "ALAN REUTHER", 400618875, "UAW RETIREE MEDICAL BENEFITS TRUST", 2019, "second_quarter", "HCR", "Implementation, Repeal and Replacement, and Improvement of ACA; Changes in Medicare Benefits and Financing; CMS initiatives on Part B and Part D drug prices; Insulin prices; measures to limit drug prices; drug price negotiation initiatives; drug patent abuses; drug advertising limits;drug price transparency; insurance market stabilization legislation; reinsurance programs; Medicare buy-in legislation; Medicare for America; surprise medical bills; CREATES Act; pay-for-delay agreements; Alexander-Murray health care legislation; FDA hearing on biosimilar insulin; repeal of Cadillac tax", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 18000, null, 0, 0, "2019-07-02T15:02:18.140000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2298867"], "units": {}, "query_ms": 2.461633994244039, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}